Treatment Outcomes of an Integrated Residential Programme for Patients with Schizophrenia and Substance Use Disorder
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: About half of all schizophrenic patients have a co-occurring substance use disorder, leading to poorer social and functional outcomes than obtained in non-abusing patients. To improve outcomes, integrated treatments have been designed that address the two conditions simultaneously. Results are, however, conflicting because the available effect studies are hampered by various methodological issues, among which are heterogeneous patient samples. Methods: In this comparative study, two well-described patient samples diagnosed with schizophrenia and co-morbid substance abuse disorders either received an integrated treatment (IDDT) or treatment as usual (TAU). Results: Patients in the IDDT condition showed significant reductions in illicit drug and alcohol use, improvements on all psychiatric symptom domains, reported higher quality of life and improved on social and community functioning. In contrast, patients’ improvements in the TAU group were moderate and limited to a few substance use and psychiatric outcomes. The TAU group had significantly higher dropout rates 6 and 12 months after baseline, suggesting that the IDDT programme was more successful in committing patients. Conclusions: Our results suggest that an integrated approach to schizophrenic patients and co-morbid substance use disorders is superior to standard treatment and may be considered as the treatment of choice for this patient group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug abuse in schizophrenic patients: clinical correlates and reasons for use
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.2.224 · Cited by 547
Drake, R. E., Mueser, K. T., Brunette, M. F., & McHugo, G. J. (2004) · Psychiatric Rehabilitation Journal · doi:10.2975/27.2004.360.374 · Cited by 459
Substance use: a powerful predictor of relapse in schizophrenia
Swofford, C. D., Kasckow, J. W., Scheller-Gilkey, G., & Inderbitzin, L. B. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00068-2 · Cited by 247 · cited 1×
“Such co-morbid substance abuse in schizophrenia is associated with poor social and clinical outcomes: patients afflicted with both conditions are more frequently hospitalised than patients with only one disorder, have more severe psychotic symptoms and have higher relapse rates [ ,”
BackgroundSubstance use disorders in schizophrenia: review, integration, and a proposed model
Blanchard, J. (2000) · Clinical Psychology Review · doi:10.1016/s0272-7358(99)00033-1 · Cited by 240
Hesse, M. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-6 · Cited by 130 · cited 1×
“], a widely used scale to distinguish between positive, negative and general symptoms. Quality of Life. Patients completed the Schizophrenia Quality of Life Scale (SQLS) [ ,”
Weiss, R. D., Griffin, M. L., Jaffee, W. B., Bender, R. E., Graff, F. S., Gallop, R. J., & Fitzmaurice, G. M. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.04.018 · Cited by 106
Cited by
Psychosocial interventions for cannabis use disorder
Gates, P. J., Sabioni, P., Copeland, J., Le Foll, B., & Gowing, L. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005336.pub4 · Cited by 282
Treatment of Dual Diagnosis Disorders
Murthy, P., & Chand, P. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328351a3e0 · Cited by 115
Kikkert, M., Goudriaan, A., de Waal, M., Peen, J., & Dekker, J. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.09.005 · Cited by 67
Metadata
- Authors
- Morrens, M., Dewilde, B., Sabbe, B., Dom, G., De Cuyper, R., & Moggi, F.
- Venue
- European Addiction Research
- Publisher
- S. Karger AG
- Published
- 2011
- Volume
- 17
- Issue
- 3
- Pages
- 154-163
- ISSN
- 1022-6877 (ISSN-L)
- 1421-9891
- OpenAlex
- W2074178915
- Cited by
- 40
- References
- 6
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment Outcomes of an Integrated Residential Programme for Patients with Schizophrenia and Substance Use Disorder. https://app.cochat.ai/papers/10.1159/000324480
- The paper
- Morrens, M., Dewilde, B., Sabbe, B., Dom, G., De Cuyper, R., & Moggi, F. (2011). Treatment Outcomes of an Integrated Residential Programme for Patients with Schizophrenia and Substance Use Disorder. European Addiction Research. https://doi.org/10.1159/000324480
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.